- Q1 2024 Sanofi SA Earnings Call TranscriptApr 25, 2024MXN802Earnings
- Sanofi SA at Barclays Global Healthcare Conference TranscriptMar 13, 2024
- Sanofi SA at Leerink Partners Global Biopharma Conference TranscriptMar 12, 2024
- Sanofi SA at TD Cowen Health Care Conference TranscriptMar 04, 2024
- Q4 2023 Sanofi SA Earnings Call TranscriptFeb 01, 2024MXN833 (+11.79%)Earnings
- Sanofi SA at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Sanofi SA R&D Day TranscriptDec 07, 2023
- Q3 2023 Sanofi SA Earnings Call TranscriptOct 27, 2023MXN972Earnings
- Sanofi SA to Discuss the Collaboration with Sanofi to Deliver Inflammatory Bowel Disease Treatment Call TranscriptOct 04, 2023
- Sanofi SA at Bank of America Merrill Lynch Global Healthcare Conference TranscriptSep 13, 2023
- Sanofi SA at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Sanofi SA at Citi BioPharma Conference TranscriptSep 06, 2023
- Q2 2023 Sanofi SA Earnings Call TranscriptJul 28, 2023MXN903Earnings
- Sanofi SA Vaccines Investor Event TranscriptJun 29, 2023
- Sanofi SA at Goldman Sachs Healthcare Conference TranscriptJun 14, 2023
- Sanofi SA Annual Shareholders Meeting (French) TranscriptMay 25, 2023
- Sanofi SA ATS Investor Call TranscriptMay 22, 2023
- Q1 2023 Sanofi SA Earnings Call TranscriptApr 27, 2023MXN1009.4 (-2.29%)Earnings
- Q4 2022 Sanofi SA Earnings Call TranscriptFeb 03, 2023MXN871.23 (+0.09%)Earnings
- Sanofi SA at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Q3 2022 Sanofi SA Earnings Call TranscriptOct 28, 2022MXN858 (+6.01%)Earnings
- Sanofi SA at Bank of America Merrill Lynch Global Healthcare Conference TranscriptSep 14, 2022
- Sanofi SA at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2022
- Sanofi SA at Citi BioPharma Conference TranscriptSep 07, 2022
- Q2 2022 Sanofi SA Earnings Call TranscriptJul 28, 2022MXN1053.03Earnings
- Sanofi SA Hemophilia Investor Event TranscriptJul 13, 2022
- Sanofi SA ESG Investor Event TranscriptJul 05, 2022
- Sanofi SA at Goldman Sachs Global Healthcare Conference TranscriptJun 14, 2022
- Sanofi SA at Jefferies Healthcare Conference TranscriptJun 09, 2022
- Sanofi SA Accounting Call TranscriptMay 18, 2022
- Sanofi SA Annual Shareholders Meeting TranscriptMay 03, 2022
- Q1 2022 Sanofi SA Earnings Call TranscriptApr 28, 2022MXN1111Earnings
- Sanofi SA And EUROAPI's Management Teams Host Capital Markets Day TranscriptApr 01, 2022
- Sanofi SA Immunology Investor Event TranscriptMar 29, 2022
- Sanofi SA at Cowen Health Care Conference (Virtual) TranscriptMar 09, 2022
- Sanofi SA at Credit Suisse London Global Healthcare Conference (Virtual) TranscriptMar 02, 2022
- Sanofi SA ACTRIMS Investor Call TranscriptFeb 25, 2022
- Sanofi SA at Citi Immuno-Oncology Summit (Virtual) TranscriptFeb 17, 2022
- Q4 2021 Sanofi SA Earnings Call TranscriptFeb 04, 2022MXN1072Earnings
- Sanofi SA at JPMorgan Healthcare Conference TranscriptJan 11, 2022
- Sanofi SA Vaccines Day TranscriptDec 01, 2021
- Q3 2021 Sanofi SA Earnings Call TranscriptOct 28, 2021MXN1019.48 (+1.24%)Earnings
- Sanofi SA at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 13, 2021
- Sanofi SA at Citi BioPharma Conference (Virtual) TranscriptSep 10, 2021
- Q2 2021 Sanofi SA Earnings Call TranscriptJul 29, 2021MXN1012.89 (-3.07%)Earnings
- Sanofi SA at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2021
- Sanofi SA Annual Shareholders Meeting TranscriptApr 30, 2021
- Q1 2021 Sanofi SA Earnings Call TranscriptApr 28, 2021MXN1036Earnings
- Sanofi SA at Barclays Global Healthcare Conference (Virtual) TranscriptMar 10, 2021
- Sanofi SA at Cowen Healthcare Conference (Virtual) TranscriptMar 02, 2021
- Sanofi SA at SVB Leerink Global Healthcare Conference (Virtual) TranscriptFeb 24, 2021
- Sanofi SA Capital Markets Day TranscriptFeb 05, 2021
- Q4 2020 Sanofi SA Earnings Call TranscriptFeb 05, 2021MXN962Earnings
- Sanofi SA at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- Sanofi SA at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 11, 2020
- Q3 2020 Sanofi SA Earnings Call TranscriptOct 29, 2020MXN979 (-4.95%)Earnings
- Sanofi SA at Sanford C Bernstein Strategic Decisions Conference (Virtual) TranscriptSep 23, 2020
- Sanofi SA at Bank of America Merrill Lynch Global Healthcare Conference (Virtual) TranscriptSep 17, 2020
- Sanofi SA at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 15, 2020
- Sanofi SA To Acquire Principia Biopharma Inc - M&A Call TranscriptAug 17, 2020
- Sanofi SA Nirsevimab R&D Investor Event TranscriptJul 30, 2020
- Q2 2020 Sanofi SA Earnings Call TranscriptJul 29, 2020MXN1152Earnings
- Sanofi SA R&D Day TranscriptJun 23, 2020
- Sanofi SA Dupixent R&D Investor Event TranscriptJun 11, 2020
- Sanofi SA at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2020
- Sanofi SA Oncology Strategy and ASCO R&D Investor Event TranscriptJun 02, 2020
- Sanofi SA Annual Shareholders Meeting TranscriptApr 28, 2020
- Q1 2020 Sanofi SA Earnings Call TranscriptApr 24, 2020MXN795.28Earnings
- Sanofi SA to Discuss Phase 2b Results Of The Investigational BTK Inhibitor ('168) In Relapsing Multiple Sclerosis Conference Call TranscriptApr 23, 2020
- Sanofi SA to Discuss Collaboration With Translate Bio to Develop a Novel mRNA Vaccine Candidate Against COVID-19 Conference Call TranscriptMar 27, 2020
- Sanofi SA at Cowen HealthCare Conference TranscriptMar 02, 2020
- Sanofi SA to Create New Industry Leading European Company to Provide API Call TranscriptFeb 24, 2020
- Q4 2019 Sanofi SA Earnings Call TranscriptFeb 06, 2020MXN795.28Earnings
- Sanofi SA at JPMorgan Healthcare Conference TranscriptJan 14, 2020
- Sanofi SA Capital Markets Day TranscriptDec 10, 2019
- Q3 2019 Sanofi SA Earnings Call TranscriptOct 31, 2019MXN795.28Earnings
- Sanofi SA at Bank of America Merrill Lynch Global Healthcare Conference TranscriptSep 19, 2019
- Lexicon Pharmaceuticals Inc Anounces Termination of its Alliance with Sanofi SA for the Development and Commercialization of Zynquista - Conference Call TranscriptSep 10, 2019
- Sanofi SA at Morgan Stanley Healthcare Conference TranscriptSep 09, 2019
- Q2 2019 Sanofi SA Earnings Call TranscriptJul 29, 2019MXN795.28Earnings
- Sanofi SA at Goldman Sachs Global Healthcare Conference TranscriptJun 12, 2019
- Sanofi SA Annual Shareholders Meeting TranscriptApr 30, 2019
- Q1 2019 Sanofi SA Earnings Call TranscriptApr 26, 2019MXN795.28Earnings
Sanofi SA at Bank of America Merrill Lynch Global Healthcare Conference Transcript
To kick off. So welcome to the next session. I'm very pleased to be able to have from Sanofi with us today. Two different areas to talk about. So we'll probably try and split the timing roughly equally between the two. So we have Naimish Patel, who's the Therapeutic Area Head, for Immunology and Inflammation. And then François Sandre, who is the Head of Vaccines in Europe, so probably two the core pieces of Sanofi that we can get to discuss here. So welcome. Thanks for the time today.
Questions & Answers
And I might kick off on the Immunology side with you, Naimish. So obviously, one of the biggest and best drivers of Sanofi at the moment is Dupixent across multiple different indications. So quite a tough act to follow if you're looking at developments. But perhaps you can just run through where you see where, particularly in atopic
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)